Alzinova AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.alzinova.com
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Phase 1
Completed
- Conditions
- Alzheimer DiseaseDementia AlzheimersDementia, Mild
- Interventions
- Other: Placebo
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Alzinova AB
- Target Recruit Count
- 33
- Registration Number
- NCT05328115
- Locations
- 🇫🇮
Clinical Research Services Turku -CRST Oy, Turku, Finland
© Copyright 2025. All Rights Reserved by MedPath